questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Lipoprotéines
Apolipoprotéines
Apolipoprotéines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Apolipoprotéines
Tests de laboratoire
Apolipoprotéines
Analyse sanguine
Maladies cardiovasculaires
Apolipoprotéines
Imagerie médicale
Apolipoprotéines
Athérosclérose
Apolipoprotéines
Symptômes
5
Douleur thoracique
Apolipoprotéines
Métabolisme lipidique
Apolipoprotéines
Cholestérol
Apolipoprotéines
Accident vasculaire cérébral
Apolipoprotéines
Prévention
5
Prévention
Apolipoprotéines
Tabagisme
Apolipoprotéines
Contrôle de santé
Apolipoprotéines
Hydratation
Apolipoprotéines
Traitements
5
Statines
Apolipoprotéines
Médicaments hypolipémiants
Apolipoprotéines
Régime alimentaire
Apolipoprotéines
Exercice physique
Apolipoprotéines
Médecine complémentaire
Apolipoprotéines
Complications
5
Maladies cardiovasculaires
Apolipoprotéines
Maladies hépatiques
Apolipoprotéines
Santé rénale
Apolipoprotéines
Inflammation
Apolipoprotéines
Facteurs de risque
5
Hérédité
Apolipoprotéines
Vieillissement
Apolipoprotéines
Mode de vie sédentaire
Apolipoprotéines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines : Questions médicales les plus fréquentes",
"headline": "Apolipoprotéines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Apolipoprotéines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipoprotéines",
"url": "https://questionsmedicales.fr/mesh/D008074",
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines",
"code": {
"@type": "MedicalCode",
"code": "D008074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines M",
"alternateName": "Apolipoproteins M",
"url": "https://questionsmedicales.fr/mesh/D000075243",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines M",
"code": {
"@type": "MedicalCode",
"code": "D000075243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines A",
"alternateName": "Apolipoproteins A",
"url": "https://questionsmedicales.fr/mesh/D001054",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines A",
"code": {
"@type": "MedicalCode",
"code": "D001054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine A-I",
"alternateName": "Apolipoprotein A-I",
"url": "https://questionsmedicales.fr/mesh/D016632",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine A-I",
"code": {
"@type": "MedicalCode",
"code": "D016632",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine A-II",
"alternateName": "Apolipoprotein A-II",
"url": "https://questionsmedicales.fr/mesh/D016633",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine A-II",
"code": {
"@type": "MedicalCode",
"code": "D016633",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine A-V",
"alternateName": "Apolipoprotein A-V",
"url": "https://questionsmedicales.fr/mesh/D000072040",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine A-V",
"code": {
"@type": "MedicalCode",
"code": "D000072040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200.575"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines B",
"alternateName": "Apolipoproteins B",
"url": "https://questionsmedicales.fr/mesh/D001055",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines B",
"code": {
"@type": "MedicalCode",
"code": "D001055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine B-48",
"alternateName": "Apolipoprotein B-48",
"url": "https://questionsmedicales.fr/mesh/D053283",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine B-48",
"code": {
"@type": "MedicalCode",
"code": "D053283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.300.240"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine B-100",
"alternateName": "Apolipoprotein B-100",
"url": "https://questionsmedicales.fr/mesh/D053299",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine B-100",
"code": {
"@type": "MedicalCode",
"code": "D053299",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.300.249"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines C",
"alternateName": "Apolipoproteins C",
"url": "https://questionsmedicales.fr/mesh/D001056",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines C",
"code": {
"@type": "MedicalCode",
"code": "D001056",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine C-I",
"alternateName": "Apolipoprotein C-I",
"url": "https://questionsmedicales.fr/mesh/D053302",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine C-I",
"code": {
"@type": "MedicalCode",
"code": "D053302",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine C-II",
"alternateName": "Apolipoprotein C-II",
"url": "https://questionsmedicales.fr/mesh/D053304",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine C-II",
"code": {
"@type": "MedicalCode",
"code": "D053304",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine C-III",
"alternateName": "Apolipoprotein C-III",
"url": "https://questionsmedicales.fr/mesh/D053305",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine C-III",
"code": {
"@type": "MedicalCode",
"code": "D053305",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines D",
"alternateName": "Apolipoproteins D",
"url": "https://questionsmedicales.fr/mesh/D053399",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines D",
"code": {
"@type": "MedicalCode",
"code": "D053399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines E",
"alternateName": "Apolipoproteins E",
"url": "https://questionsmedicales.fr/mesh/D001057",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines E",
"code": {
"@type": "MedicalCode",
"code": "D001057",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine E2",
"alternateName": "Apolipoprotein E2",
"url": "https://questionsmedicales.fr/mesh/D053329",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine E2",
"code": {
"@type": "MedicalCode",
"code": "D053329",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine E3",
"alternateName": "Apolipoprotein E3",
"url": "https://questionsmedicales.fr/mesh/D053318",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine E3",
"code": {
"@type": "MedicalCode",
"code": "D053318",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine E4",
"alternateName": "Apolipoprotein E4",
"url": "https://questionsmedicales.fr/mesh/D053327",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine E4",
"code": {
"@type": "MedicalCode",
"code": "D053327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines L",
"alternateName": "Apolipoproteins L",
"url": "https://questionsmedicales.fr/mesh/D000075943",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines L",
"code": {
"@type": "MedicalCode",
"code": "D000075943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine L1",
"alternateName": "Apolipoprotein L1",
"url": "https://questionsmedicales.fr/mesh/D000075944",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine L1",
"code": {
"@type": "MedicalCode",
"code": "D000075944",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.750.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines",
"alternateName": "Apolipoproteins",
"code": {
"@type": "MedicalCode",
"code": "D001053",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joan Carles Escolà-Gil",
"url": "https://questionsmedicales.fr/author/Joan%20Carles%20Escol%C3%A0-Gil",
"affiliation": {
"@type": "Organization",
"name": "Institut de Recerca Sant Pau, 08041 Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Robert A Hegele",
"url": "https://questionsmedicales.fr/author/Robert%20A%20Hegele",
"affiliation": {
"@type": "Organization",
"name": "Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Medicine, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Catherine Mounier",
"url": "https://questionsmedicales.fr/author/Catherine%20Mounier",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire du Métabolisme Moléculaire des Lipides, Université du Québec à Montréal, Département des Sciences Biologiques, Case Postale 8888, Succursale Centre-ville, Montréal, QC H3C 3P8, Canada."
}
},
{
"@type": "Person",
"name": "Allan Sniderman",
"url": "https://questionsmedicales.fr/author/Allan%20Sniderman",
"affiliation": {
"@type": "Organization",
"name": "Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "To run or not to run? Differences in implicit attitudes towards running: An EEG study.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37647993",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbr.2023.114637"
}
},
{
"@type": "ScholarlyArticle",
"name": "Muscle synergies during the walk-run and run-walk transitions.",
"datePublished": "2024-10-22",
"url": "https://questionsmedicales.fr/article/39465151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.18162"
}
},
{
"@type": "ScholarlyArticle",
"name": "Running towards injury? A prospective investigation of factors associated with running injuries.",
"datePublished": "2023-08-17",
"url": "https://questionsmedicales.fr/article/37590281",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0288814"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complexity of Running and Its Relationship with Joint Kinematics during a Prolonged Run.",
"datePublished": "2022-08-05",
"url": "https://questionsmedicales.fr/article/35955013",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19159656"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Highly Cushioned and Resilient Racing Shoes on Running Economy at Slower Running Speeds.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36626911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1123/ijspp.2022-0227"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lipoprotéines",
"item": "https://questionsmedicales.fr/mesh/D008074"
},
{
"@type": "ListItem",
"position": 5,
"name": "Apolipoprotéines",
"item": "https://questionsmedicales.fr/mesh/D001053"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Apolipoprotéines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Apolipoprotéines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Apolipoprotéines",
"description": "Comment diagnostiquer une anomalie des apolipoprotéines ?\nQuels tests sont utilisés pour évaluer les apolipoprotéines ?\nLes apolipoprotéines sont-elles liées aux maladies cardiovasculaires ?\nPeut-on détecter des apolipoprotéines par imagerie ?\nQuels symptômes peuvent indiquer un problème d'apolipoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Running#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Apolipoprotéines",
"description": "Quels symptômes sont associés à des niveaux élevés d'apolipoprotéines ?\nLes apolipoprotéines affectent-elles le métabolisme ?\nComment les apolipoprotéines influencent-elles le cholestérol ?\nDes symptômes neurologiques peuvent-ils être liés aux apolipoprotéines ?\nLes apolipoprotéines sont-elles liées à l'obésité ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Running#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Apolipoprotéines",
"description": "Comment prévenir les anomalies d'apolipoprotéines ?\nLe tabagisme influence-t-il les apolipoprotéines ?\nLe stress a-t-il un impact sur les apolipoprotéines ?\nLes contrôles réguliers de santé sont-ils importants ?\nL'hydratation joue-t-elle un rôle dans la santé des apolipoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Running#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Apolipoprotéines",
"description": "Quels traitements existent pour les anomalies d'apolipoprotéines ?\nLes médicaments peuvent-ils normaliser les apolipoprotéines ?\nLe régime alimentaire influence-t-il les apolipoprotéines ?\nLes exercices physiques affectent-ils les niveaux d'apolipoprotéines ?\nLes traitements naturels peuvent-ils aider les apolipoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Running#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Apolipoprotéines",
"description": "Quelles complications peuvent survenir avec des apolipoprotéines anormales ?\nLes apolipoprotéines anormales peuvent-elles causer des diabètes ?\nLes troubles hépatiques sont-ils liés aux apolipoprotéines ?\nLes apolipoprotéines affectent-elles la santé rénale ?\nLes apolipoprotéines peuvent-elles influencer l'inflammation ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Running#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Apolipoprotéines",
"description": "Quels sont les principaux facteurs de risque pour les anomalies d'apolipoprotéines ?\nL'hérédité joue-t-elle un rôle dans les anomalies d'apolipoprotéines ?\nLe vieillissement influence-t-il les niveaux d'apolipoprotéines ?\nLe sexe a-t-il un impact sur les apolipoprotéines ?\nLe mode de vie sédentaire est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Running#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des apolipoprotéines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux d'apolipoprotéines sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les apolipoprotéines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages des apolipoprotéines A1 et B sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines sont-elles liées aux maladies cardiovasculaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux d'apolipoprotéines sont associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des apolipoprotéines par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la détection se fait principalement par des analyses sanguines, pas par imagerie."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème d'apolipoprotéines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'athérosclérose peuvent indiquer des anomalies d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à des niveaux élevés d'apolipoprotéines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés peuvent entraîner des douleurs thoraciques ou des crises cardiaques."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines affectent-elles le métabolisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles jouent un rôle clé dans le métabolisme lipidique et peuvent causer des troubles."
}
},
{
"@type": "Question",
"name": "Comment les apolipoprotéines influencent-elles le cholestérol ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles transportent le cholestérol dans le sang, influençant les niveaux de cholestérol total."
}
},
{
"@type": "Question",
"name": "Des symptômes neurologiques peuvent-ils être liés aux apolipoprotéines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent être associées à des troubles neurologiques comme l'AVC."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines sont-elles liées à l'obésité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent être observés chez les personnes obèses."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies d'apolipoprotéines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain avec une alimentation équilibrée et de l'exercice régulier."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les apolipoprotéines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque d'anomalies d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les apolipoprotéines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter les niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Les contrôles réguliers de santé sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers aident à détecter les anomalies tôt."
}
},
{
"@type": "Question",
"name": "L'hydratation joue-t-elle un rôle dans la santé des apolipoprotéines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation est essentielle pour le métabolisme lipidique."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies d'apolipoprotéines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les statines et les changements de mode de vie sont souvent recommandés."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils normaliser les apolipoprotéines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aider à réguler les niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Le régime alimentaire influence-t-il les apolipoprotéines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime riche en fibres et faible en graisses saturées peut aider."
}
},
{
"@type": "Question",
"name": "Les exercices physiques affectent-ils les niveaux d'apolipoprotéines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer les niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Les traitements naturels peuvent-ils aider les apolipoprotéines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes et suppléments peuvent soutenir la santé lipidique, mais consultez un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des apolipoprotéines anormales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies cardiovasculaires, des AVC et des troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines anormales peuvent-elles causer des diabètes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont liées à un risque accru de diabète de type 2."
}
},
{
"@type": "Question",
"name": "Les troubles hépatiques sont-ils liés aux apolipoprotéines ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent être associés à des maladies hépatiques."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines affectent-elles la santé rénale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent contribuer à des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines peuvent-elles influencer l'inflammation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés sont souvent associés à des états inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les anomalies d'apolipoprotéines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme, une mauvaise alimentation et le manque d'exercice sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les anomalies d'apolipoprotéines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le vieillissement influence-t-il les niveaux d'apolipoprotéines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner des modifications des niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Le sexe a-t-il un impact sur les apolipoprotéines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des différences hormonales peuvent influencer les niveaux d'apolipoprotéines entre les sexes."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire augmente le risque d'anomalies d'apolipoprotéines."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institut de Recerca Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
Publications dans "Apolipoprotéines" :
3 publications dans cette catégorie
Affiliations :
Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Medicine, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada.
Publications dans "Apolipoprotéines" :
3 publications dans cette catégorie
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Laboratoire du Métabolisme Moléculaire des Lipides, Université du Québec à Montréal, Département des Sciences Biologiques, Case Postale 8888, Succursale Centre-ville, Montréal, QC H3C 3P8, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
Mental Health and Society Division, Douglas Mental Health University Institute, Montreal, QC, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Institute of Mental Health, Hebei Mental Health Centre, Hebei, China.
Department of Sleep Medicine, Hebei Psychiatric Hospital, Hebei, China.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Institute of Mental Health, Hebei Mental Health Centre, Hebei, China. yunshucoffee@sina.com.
Department of Sleep Medicine, Hebei Psychiatric Hospital, Hebei, China. yunshucoffee@sina.com.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 16 Lin Cui Road, Beijing, 100101, China. zhangxy@psych.ac.cn.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology University of Kansas Medical Center, Kansas City, KS 66160, USA.
University of Kansas Alzheimer's Disease Center, Kansas City, KS 66160, USA.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology & Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada. Electronic address: mlk@robarts.ca.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
School of Public Health, Guangdong Medical University, Zhanjiang, 524023, China.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Public Health Foundation India, Gurugram, Haryana, India; Centre for Chronic Disease Control, New Delhi, India; London School of Hygiene & Tropical Medicine, United Kingdom. Electronic address: dprabhakaran@ccdcindia.org.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Hebei Medical University, Shijiazhuang, People's Republic of China.
Department of Endocrinology, Hebei General Hospital, Shijiazhuang, People's Republic of China.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Center for Biomedical Research (CEBIOR), Faculty of Medicine, Universitas Diponegoro, Semarang 50275, Central Java, Indonesia.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Department of Psychology, University of Marlyand, College Park, MD 20742, USA.
MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Division of Biostatistics, School of Medicine, University of California Davis, Davis, CA 95616, USA.
Publications dans "Apolipoprotéines" :
To understand the reasons for individuals do or do not exercise, we examined differences in implicit (affective and instrumental) attitudes between runners and non-runners....
In conjunction with electroencephalography (EEG) technology, 31 participants completed the affective and instrumental implicit associations test (IAT)....
Behavioural results showed that runners had more positive implicit (affective and instrumental) attitudes than non-runners. EEG results further explained the underlying mechanisms for the differences,...
Higher levels of neural processing efficiency were required for runners to perceive affective expectations towards running. Furthermore, ERP indicators (N1 amplitudes of incompatible tasks) can be use...
Muscular synergies could represent the patterns of muscular activation used by the central nervous system (CNS) to simplify the production of movement. Studies in walking-running transitions described...
Twenty-four trained men participated in this study. A variable speed protocol on a treadmill was developed to record the activity of 14 muscle during walking, running and relative transitions. The pro...
We described four different transition strides, two for increasing speed transitions, and two for decreasing speed transitions. Four to six synergy modules were found in each condition. According to t...
Transition occurred at step level, and transition strides were composed by walk-like and run-like steps. Compared with previous studies in running and walking, both transitions needed earlier activati...
Given the high incidence and heavy burden of running related injuries, large-scale, prospective multifactorial investigations examining potential risk factors are warranted. This study aimed to identi...
Prospective cohort study....
Two hundred and seventy-four recreational runners were recruited. Clinical measures (strength, range of motion, foot position), injury and training history (via questionnaire), impact loading (via acc...
Of the 225 runners included in the final analysis 52% experienced a running related injury. Injury history in the past year, less navicular drop, and measures of running technique (knee, hip, and pelv...
This study found a number of clinical and running technique factors to be associated with prospective running related injuries among recreational runners. With the exception of injury history, the fac...
We investigated the effect of prolonged running on joint kinematics and its association with stride complexity between novice and elite runners. Ten elite marathoners and eleven healthy individuals to...
The Nike Vaporfly line of running shoes improves running economy by ∼2.7% to 4.2% at running speeds of 13 to 18 km·h-1. It is unclear whether similar benefits are conferred at slower speeds. Our purpo...
Sixteen runners completed 4 × 5-minute trials at both 10 and 12 km·h-1 on the same day. Each shoe was tested twice at each speed in a counterbalanced, mirrored sequence. Data are displayed as mean (SD...
A 2-way repeated-measures analysis of variance showed a significant shoe × speed interaction for oxygen consumption (P = .021). At 12 km·h-1, oxygen consumption (in mL·kg-1·min-1) was lower (-1.4% [1....
From these data, it appears that the VFN2 still enhances running economy at 10 and 12 km·h-1; however, these benefits are smaller in magnitude compared with previous research at faster speeds....
Gait retraining can be effective in altering lower extremity biomechanics and reducing risk of injury. In attempts to alter running gait, previous studies used metronomes to manipulate cadence....
The aim of this study was to determine if manipulating running cadence via music could alter lower extremity biomechanics....
Eighteen runners ran at a self-selected speed (SS) and ran to music where the beats per minute (bpm) of the songs was increased by 5% (+5%) and 10% (+10%). Kinematic and kinetic data were collected wi...
There was a significant main effect for bpm on the discrete metrics. Post hoc tests showed significant differences in heartrate from SS to + 5%, + 5% to + 10%, and SS to 10%. There were no significant...
In the current study, listening to music with faster bpm was not shown to increase cadence and decrease peak tibial accelerations during running....
Runners have a high risk of acquiring a running-related injury. Understanding the mechanisms of impact force attenuation into the body when a runner fatigues might give insight into the role of runnin...
How do running kinematics change due to running-induced fatigue? And what is the influence of experience level on changes in running kinematics due to fatigue?...
Three electronic databases were searched: PubMed, Web of Science, and Scopus. This resulted in 33 articles and 19 kinematic quantities being included in this review. A quality assessment was performed...
Main findings included an increase in peak acceleration at the tibia and a decrease in leg stiffness after a fatiguing protocol. Additionally, level running-induced fatigue increased knee flexion at i...
Running is a common recreational activity, and the number of long-distance-race participants is continuously growing. It is well-established that regular physical activity can prevent and manage non-c...
To examine the relationships of a 14.5 km running performance with the cardiopulmonary parameters of amateur runners, a cross-sectional study design was applied. Fifteen (eleven men and four women) re...
The results showed that the 14.5 km race performance time (73.8 ± 9.7 min) significantly correlated with the cardiopulmonary-exercise-testing speed-related indices at specific submaximal and maximal w...
There is a better correlation of the 14.5 km running performance of recreational long-distance runners with the cardiopulmonary-exercise-testing speed-related indices at specific workloads than with t...
Advancements in running shoe technology over the last 5 years have sparked controversy in athletics as linked with clear running economy and performance enhancements. Early debates mainly surrounded '...
Multiple health behaviour change is a viable strategy to promote health outcomes. An example is the use of running behaviour to support smoking cessation in the group-mediated Run to Quit program. On ...
We analyzed data collected from 450 adult individuals (70.67% female, and 92.44% white) during the program evaluation of Run to Quit from 2016 to 2018. Participants completed assessments at week 1 (ba...
Changes in running self-efficacy, running frequency, and individual attractions to the group exercise tasks were significant and meaningful predictors of change in running identity, whereas changes in...
Consistent with identity theories and past research, ensuring individuals develop a sense of efficacy and enjoy group exercise tasks both represent viable strategies to enhance exercise identity. Incl...